The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and tolerability of dostarlimab in combination antiretroviral therapy–refractory HIV-associated Kaposi sarcoma: Preliminary results from the StarKap phase Ib trial.
 
Claudia Fulgenzi
No Relationships to Disclose
 
Alessia Dalla Pria
No Relationships to Disclose
 
Alberto Leone
No Relationships to Disclose
 
Maria Matinez
No Relationships to Disclose
 
Elena Ferrer Martinez Del Peral
No Relationships to Disclose
 
Maria Eleanor Flores
No Relationships to Disclose
 
Erik Ramon
No Relationships to Disclose
 
Jack Leslie
No Relationships to Disclose
 
Michael Wang
No Relationships to Disclose
 
Xiao Ning Xu
No Relationships to Disclose
 
Catherine Reynolds
No Relationships to Disclose
 
Daniel Altmann
No Relationships to Disclose
 
Rosemary Boyton
No Relationships to Disclose
 
Mark Bower
Honoraria - Gilead Sciences; ViiV Healthcare
 
David Pinato
Honoraria - Avammune; Boston Scientific; Bristol-Myers Squibb; Da Volterra; Galapagos NV; Lift Biosciences; Mursla Bio; Parabilis; Roche/Genentech; Starpharma; TERUMO
Consulting or Advisory Role - AstraZeneca; Da Volterra; EISAI; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley